Cargando…
A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain
The identification of antibody variable regions in the heavy (V(H)) and light (V(L)) chains from hybridomas is necessary for the production of recombinant, sequence-defined monoclonal antibodies (mAbs) and antibody derivatives. This process has received renewed attention in light of recent reports o...
Autores principales: | Pornnoppadol, Ghasidit, Zhang, Boya, Desai, Alec A., Berardi, Anthony, Remmer, Henriette A., Tessier, Peter M., Greineder, Colin F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504763/ https://www.ncbi.nlm.nih.gov/pubmed/34634047 http://dx.doi.org/10.1371/journal.pone.0252558 |
Ejemplares similares
-
A murine hybridoma with large cytoplasmic inclusions of kappa light chains
Publicado: (1987) -
Generation of the first monoclonal antibody using mouse hybridomas
por: Falini, Brunangelo
Publicado: (2022) -
Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis
por: Zupancic, Jennifer M., et al.
Publicado: (2021) -
The Landscape of Cytogenetic Aberrations in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma
por: He, Haiyan, et al.
Publicado: (2023) -
Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening
por: Schardt, John S., et al.
Publicado: (2021)